Linda Peckel

THRIVE scores not only accurately predicted good and poor outcomes in stroke patients following IVT or ET, but also the degree of ischemia following these treatments.

An increase in weight ≥5% was associated with lower cognitive scores.

Only 16% of patients had an adequate response to conventional therapy, with patients who didn’t considered “non-responders.”

Patients with the highest predictive scores faced a greater risk of developing cognitive impairment and dementia in the first 10 years after disease onset.

More targeted injection sites may improve efficacy and the overall patient experience in chronic migraine.

Despite promising results in earlier studies, researchers found no benefit for creatine in patients with early Huntington disease.

Debate continues as to whether ocular tremor represents a clinical marker of Parkinson’s disease or a compensatory movement related to other bodily tremors.

The majority of centers follow protocols for administration of onabotulinumtoxinA.

The findings add to a growing body of evidence that shows a strong connection between pathological findings of CTE and athletes who suffer repeated head trauma.

Longer durations and greater depth of cooling did not reduce later mortality and disability.

The study reconfirmed the positive effects of exercise on fatigue in multiple sclerosis.

Although spot sign predicted ICH expansion, it proved to be a less robust diagnostic marker than demonstrated by previous single-center cohort studies.

The FDA-sponsored study sought to evaluate the bioequivalence of 2 generic forms of the popular epilepsy treatment lamotrigine.

Accountable Care Organizations (ACOs) are increasingly taking responsibility for health care management, record-keeping, and payment.

Reduced door-to-needle times have been shown to improve outcomes after stroke.

Children in the youngest age group consistently reported worse scores on all measures than those in the highest age group.

The main differentiating factor was the presence of the APOE ε4 allele.

Patients in the treatment group had improved ON and OFF times and no worsening of motor function.

The main differentiating factor was the presence of the APOE ε4 allele.

“[This drug] is so inexpensive that it can be prescribed immediately with no insurance issues and is affordable for many who have no insurance,” Dr Metz said.

Investigators examined blood plasma samples taken annually from a cohort of 201 huntingtin gene (HTT) carriers.

Risk for symptomatic intracranial hemorrhage after endovascular treatment for acute ischemic stroke is significantly higher in real-world practice than rates reported by clinical trials.

Antidepressant use before conception was associated with a higher risk of autism spectrum disorders compared with antidepressant use during pregnancy.

Investigators identified a series of prodromal signs that appear anywhere from 1 to 18 years before a clinical diagnosis of SCA2.

Patients with multiple system atrophy with parkinsonism face the greatest risk for death among synucleinopathies.

Although the study could not confirm that it is a definitive biomarker, the test was highly predictive of outcomes in a cohort of 112 patients with MCI.

Intracranial atherosclerosis was lower in patients with migraine compared with those without migraine.

In a group undergoing either blepharoplasty or ptosis repair, patients who underwent ptosis repair saw greater improvement in headache symptoms.

The difference in response in the ropivicaine and saline groups was insignificant, suggesting a placebo effect.

For survivors of nontraumatic cardiac arrest, brain injury becomes a major factor in disability and long-term survival.